Expert NetworkExpert InterviewAKRO

Slingshot members are talking to an expert! The topic is:

Discussing the NASH landscape in the aftermath of the Akero's efruxifermin results

Executed on:Oct 13, 2023 12:00 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Yale University
  • Academic hepatologist, Associate Professor of Medicine (Digestive Diseases) and Director, Yale Viral Hepatitis Program.
  • Treats patients with chronic liver diseases including the entire spectrum from cirrhosis, liver failure, and post-transplant; Approximately 5-10% of his patients have chronic pruritus symptoms, 200 patients with biopsy-proven NASH and a larger cohort of NAFLD, and 70 patients with PBC/PSC.
  • Has served on the national steering committees for large observational cohort studies for liver disease and has published over 100 papers in the area of GI and liver diseases.

Interview Goal

This conversation will focus on Akero's recent announcement of their Phase 2b SYMMETRY study results evaluating efruxifermin (EFX) in patients with compensated cirrhosis due to NASH.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.